NCT05728541 2023-02-17
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown
CSPC Ouyi Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.